webinar register page

Webinar banner
Virtual Office Hours: Medications for Opioid Use Disorder and COVID-19


May 13, 2020 03:46 PM

* Required information


Dr. David Kan
Chief Medical Officer @Bright Heart Health
Dr. David Kan is a psychiatrist who is board-certified in Addiction Medicine. Dr. Kan is the immediate past-president of the California Society of Addiction Medicine (CSAM). Dr. Kan has testified in favor the establishment of Safe Injection Facilities/Safe Consumptions Sites/Harm Reduction Centers for four consecutive years. Dr. Kan is the Chief Medical Officer of Bright Heart Health (BHH). BHH is a telemedicine provider of addiction medicine services active in 40+ states.
Ann Breidenstein
Harm Reduction Supportive Counselor @Evergreen Health Services
Ann Breidenstein is the Harm Reduction Supportive Counselor at Evergreen Health Services where she specializes in providing safer injection counseling in the Syringe Exchange Program. In this role, Ann provides individualized safer use plans, conducts community based outreach with peers and supports the rest of the exchange staff in building knowledge related to the use of substances and overdose prevention strategies. Prior to being employed at Evergreen Health Services, Ann was the Human Trafficking Program Manager for the Western District of NY and had worked as an advocate since 2008. Ann is proud to have 15 years of experience in direct patient services and hopes to receive her RN in 2021.
Louise Vincent MPH
Executive Director @NC Survivors Union
Louise Vincent is Director of the Urban Survivors Union in North Carolina, USA and the National Drug User Union, an organization of former and active drug users who have come together to provide services for a community that is under-represented and underserved. She has first-hand knowledge of the communities that sell and use drugs and works to educate this community regarding harm reduction. Louise is passionate about the need for drug user networks and unions to engage with policymakers at state and national levels to correct misconceptions about people who use drugs (PWUD). She provides valuable insight on policies that both help and hinder engagement and retention of PWUD in harm reduction services and the impact that inequity of services between states has on this community.